Arrowhead Pharmaceuticals Inc (ARWR)

Operating profit margin

Sep 30, 2025 Sep 30, 2024 Sep 30, 2023 Sep 30, 2022 Sep 30, 2021
Operating income US$ in thousands 98,346 -601,080 -205,002 -178,507 -149,036
Revenue US$ in thousands 829,448 3,551 240,735 243,231 138,287
Operating profit margin 11.86% -16,927.06% -85.16% -73.39% -107.77%

September 30, 2025 calculation

Operating profit margin = Operating income ÷ Revenue
= $98,346K ÷ $829,448K
= 11.86%


Peer comparison

Sep 30, 2025

Company name
Symbol
Operating profit margin
Arrowhead Pharmaceuticals Inc
ARWR
11.86%
Biomarin Pharmaceutical Inc
BMRN
16.97%
Regeneron Pharmaceuticals Inc
REGN
28.10%